Omega Therapeutics Inc (OMGA)
0.786
+0.01
(+1.29%)
USD |
NASDAQ |
Nov 22, 16:00
0.765
-0.02
(-2.67%)
After-Hours: 20:00
Omega Therapeutics Debt to Equity Ratio: 1.350 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.350 |
| June 30, 2024 | 0.6439 |
| March 31, 2024 | 0.4328 |
| December 31, 2023 | 0.3255 |
| September 30, 2023 | 0.2612 |
| June 30, 2023 | 0.2081 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.1622 |
| December 31, 2022 | 0.1881 |
| September 30, 2022 | 0.1489 |
| June 30, 2022 | 0.1264 |
| March 31, 2022 | 0.1096 |
| December 31, 2021 | 0.099 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.099
Minimum
Dec 2021
1.350
Maximum
Sep 2024
0.338
Average
0.1981
Median
Debt to Equity Ratio Benchmarks
| Moderna Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 152.73M |
| Total Liabilities (Quarterly) | 141.18M |
| Shareholders Equity (Quarterly) | 11.54M |
| Current Ratio | 1.611 |
| Net Debt Paydown Yield | 1.30% |